keyword
MENU ▼
Read by QxMD icon Read
search

musso giovanni

keyword
https://www.readbyqxmd.com/read/27880988/pioglitazone-for-advanced-fibrosis-in-nash-new-evidence-new-challenges
#1
Giovanni Musso, Maurizio Cassader, Elena Paschetta, Roberto Gambino
No abstract text is available yet for this article.
November 23, 2016: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://www.readbyqxmd.com/read/27770583/a-population-based-study-of-chronic-myeloid-leukemia-patients-treated-with-imatinib-in-first-line
#2
Fausto Castagnetti, Francesco Di Raimondo, Antonio De Vivo, Antonio Spitaleri, Gabriele Gugliotta, Francesco Fabbiano, Isabella Capodanno, Donato Mannina, Marzia Salvucci, Agostino Antolino, Roberto Marasca, Maurizio Musso, Monica Crugnola, Stefana Impera, Elena Trabacchi, Caterina Musolino, Francesco Cavazzini, Giuseppe Mineo, Patrizia Tosi, Carmela Tomaselli, Michele Rizzo, Sergio Siragusa, Miriam Fogli, Riccardo Ragionieri, Alessandro Zironi, Simona Soverini, Giovanni Martinelli, Michele Cavo, Paolo Vigneri, Fabio Stagno, Gianantonio Rosti, Michele Baccarani
Chronic myeloid leukemia (CML) treatment is based on company-sponsored and academic trials testing different tyrosine kinase inhibitors (TKIs) as first-line therapy. These studies included patients selected according to many inclusion-exclusion criteria, particularly age and comorbidities, with specific treatment obligations. In daily clinical practice (real-life), inclusion-exclusion criteria do not exist and the treatment outcome does not only depend on the choice of first-line TKI, but also on second- and third-line TKIs...
October 22, 2016: American Journal of Hematology
https://www.readbyqxmd.com/read/27660122/fatty-liver-and-chronic-kidney-disease-novel-mechanistic-insights-and-therapeutic-opportunities
#3
REVIEW
Giovanni Musso, Maurizio Cassader, Solomon Cohney, Franco De Michieli, Silvia Pinach, Francesca Saba, Roberto Gambino
Chronic kidney disease (CKD) is a risk factor for end-stage renal disease (ESRD) and cardiovascular disease (CVD). ESRD or CVD develop in a substantial proportion of patients with CKD receiving standard-of-care therapy, and mortality in CKD remains unchanged. These data suggest that key pathogenetic mechanisms underlying CKD progression go unaffected by current treatments. Growing evidence suggests that nonalcoholic fatty liver disease (NAFLD) and CKD share common pathogenetic mechanisms and potential therapeutic targets...
October 2016: Diabetes Care
https://www.readbyqxmd.com/read/27521506/new-pharmacologic-agents-that-target-inflammation-and-fibrosis-in-nonalcoholic-steatohepatitis-related-kidney-disease
#4
Giovanni Musso, Franco De Michieli, Daria Bongiovanni, Renato Parente, Luciana Framarin, Nicola Leone, Mara Berrutti, Roberto Gambino, Maurizio Cassader, Solomon Cohney, Elena Paschetta
Epidemiologic data show an association between the prevalence and severity of nonalcoholic fatty liver disease and the incidence and stage of chronic kidney disease (CKD); furthermore, nonalcoholic steatohepatitis (NASH)-related cirrhosis has a higher risk of renal failure, a greater necessity for simultaneous liver-kidney transplantation, and a poorer renal outcome than cirrhosis of other etiologies even after simultaneous liver-kidney transplantation. These data suggest that NASH and CKD share common proinflammatory and profibrotic mechanisms of progression, which are targeted incompletely by current treatments...
August 10, 2016: Clinical Gastroenterology and Hepatology
https://www.readbyqxmd.com/read/27510649/erratum-to-donor-age-and-long-term-culture-do-not-negatively-influence-the-stem-potential-of-limbal-fibroblast-like-stem-cells
#5
Laura Tomasello, Rosa Musso, Giovanni Cillino, Maria Pitrone, Giuseppe Pizzolanti, Antonina Coppola, Walter Arancio, Gianluca Di Cara, Ida Pucci-Minafra, Salvatore Cillino, Carla Giordano
No abstract text is available yet for this article.
August 10, 2016: Stem Cell Research & Therapy
https://www.readbyqxmd.com/read/27296060/donor-age-and-long-term-culture-do-not-negatively-influence-the-stem-potential-of-limbal-fibroblast-like-stem-cells
#6
Laura Tomasello, Rosa Musso, Giovanni Cillino, Maria Pitrone, Giuseppe Pizzolanti, Antonina Coppola, Walter Arancio, Gianluca Di Cara, Ida Pucci-Minafra, Salvatore Cillino, Carla Giordano
BACKGROUND: In regenerative medicine the maintenance of stem cell properties is of crucial importance. Ageing is considered a cause of reduced stemness capability. The limbus is a stem niche of easy access and harbors two stem cell populations: epithelial stem cells and fibroblast-like stem cells. Our aim was to investigate whether donor age and/or long-term culture have any influence on stem cell marker expression and the profiles in the fibroblast-like stem cell population. METHODS: Fibroblast-like stem cells were isolated and digested from 25 limbus samples of normal human corneo-scleral rings and long-term cultures were obtained...
2016: Stem Cell Research & Therapy
https://www.readbyqxmd.com/read/27127905/combination-of-bendamustine-and-rituximab-as-front-line-therapy-for-patients-with-chronic-lymphocytic-leukaemia-multicenter-retrospective-clinical-practice-experience-with-279-cases-outside-of-controlled-clinical-trials
#7
Massimo Gentile, Katja Zirlik, Stefania Ciolli, Francesca R Mauro, Nicola Di Renzo, Lucia Mastrullo, Francesco Angrilli, Stefano Molica, Giovanni Tripepi, Annamaria Giordano, Francesco Di Raimondo, Carmine Selleri, Marta Coscia, Maurizio Musso, Lorella Orsucci, Donato Mannina, Angela Rago, Angela Giannotta, Felicetto Ferrara, Yair Herishanu, Lev Shvidel, Tamar Tadmor, Ilaria Scortechini, Fiorella Ilariucci, Roberta Murru, Attilio Guarini, Gerardo Musuraca, Giuseppe Mineo, Iolanda Vincelli, Annalisa Arcari, Giuseppe Tarantini, Giuseppe Caparrotti, Annalisa Chiarenza, Luciano Levato, Maria Rosaria Villa, Maria Rosaria De Paolis, Pier Luigi Zinzani, Aaron Polliack, Fortunato Morabito
Recently, encouraging results in terms of safety and efficacy have been obtained using bendamustine-rituximab (BR) in untreated chronic lymphocytic leukaemia (CLL) patients enrolled in a phase II study. Here, we report a retrospective international multicenter study of CLL patients treated with BR as front-line therapy. The cohort included 279 patients with progressive CLL from 33 centers (29 Italian, 3 Israeli and 1 German) who received at least 1 cycle of BR as first-line treatment during the 2008-2014 period...
June 2016: European Journal of Cancer
https://www.readbyqxmd.com/read/26794269/non-alcoholic-steatohepatitis-emerging-molecular-targets-and-therapeutic-strategies
#8
REVIEW
Giovanni Musso, Maurizio Cassader, Roberto Gambino
Non-alcoholic fatty liver disease - the most common chronic liver disease - encompasses a histological spectrum ranging from simple steatosis to non-alcoholic steatohepatitis (NASH). Over the next decade, NASH is projected to be the most common indication for liver transplantation. The absence of an effective pharmacological therapy for NASH is a major incentive for research into novel therapeutic approaches for this condition. The current focus areas for research include the modulation of nuclear transcription factors; agents that target lipotoxicity and oxidative stress; and the modulation of cellular energy homeostasis, metabolism and the inflammatory response...
April 2016: Nature Reviews. Drug Discovery
https://www.readbyqxmd.com/read/26573228/lps-induced-tnf-%C3%AE-factor-mediates-pro-inflammatory-and-pro-fibrogenic-pattern-in-non-alcoholic-fatty-liver-disease
#9
Sara Ceccarelli, Nadia Panera, Marco Mina, Daniela Gnani, Cristiano De Stefanis, Annalisa Crudele, Chiara Rychlicki, Stefania Petrini, Giovannella Bruscalupi, Laura Agostinelli, Laura Stronati, Salvatore Cucchiara, Giovanni Musso, Cesare Furlanello, Gianluca Svegliati-Baroni, Valerio Nobili, Anna Alisi
Lipopolysaccharide (LPS) is currently considered one of the major players in non-alcoholic fatty liver disease (NAFLD) pathogenesis and progression. Here, we aim to investigate the possible role of LPS-induced TNF-α factor (LITAF) in inducing a pro-inflammatory and pro-fibrogenic phenotype of non-alcoholic steatohepatitis (NASH).We found that children with NAFLD displayed, in different liver-resident cells, an increased expression of LITAF which correlated with histological traits of hepatic inflammation and fibrosis...
December 8, 2015: Oncotarget
https://www.readbyqxmd.com/read/26463349/omega-3-fatty-acids-mechanisms-of-benefit-and-therapeutic-effects-in-pediatric-and-adult-nafld
#10
REVIEW
Valerio Nobili, Anna Alisi, Giovanni Musso, Eleonora Scorletti, Philip C Calder, Christopher D Byrne
Non-alcoholic fatty liver disease (NAFLD) is currently considered the most common liver disease in industrialized countries, and it is estimated that it will become the most frequent indication for liver transplantation in the next decade. NAFLD may be associated with moderate (i.e. steatosis) to severe (i.e. steatohepatitis and fibrosis) liver damage and affects all age groups. Furthermore, subjects with NAFLD may be at a greater risk of other obesity-related complications later in life, and people with obesity and obesity-related complications (e...
2016: Critical Reviews in Clinical Laboratory Sciences
https://www.readbyqxmd.com/read/26460265/klotho-a-new-marker-for-osteoporosis-and-muscle-strength-in-%C3%AE-thalassemia-major
#11
Alessandro Baldan, Andrea Giusti, Cristina Bosi, Cristina Malaventura, Marco Musso, Gian Luca Forni, Stefano Volpato, Giovanni Zuliani, Caterina Borgna-Pignatti
Aim of this study was to compare plasma levels of the secreted protein Klotho in β-thalassemia major patients and in healthy controls. Also, we examined the existence of correlations between the protein level and osteoporosis, poor muscle strength and fractures. A total of 106 patients with β-thalassemia major and 95 healthy blood donors were enrolled. Klotho level in plasma was measured by mean of an ELISA test and the hand-grip strength using a dynamometer. Intact parathyroid hormone (PTH), 25-hydroxy vitamin D (Vitamin D), serum calcium (Ca), phosphate (P), total alkaline phosphatase (ALP), ferritin, creatinine were measured by standard clinical techniques...
December 2015: Blood Cells, Molecules & Diseases
https://www.readbyqxmd.com/read/26432021/emerging-liver-kidney-interactions-in-nonalcoholic-fatty-liver-disease
#12
REVIEW
Giovanni Musso, Maurizio Cassader, Solomon Cohney, Silvia Pinach, Francesca Saba, Roberto Gambino
Mounting evidence connects non-alcoholic fatty liver disease (NAFLD) to chronic kidney disease (CKD). We review emerging mechanistic links between NAFLD and CKD, including altered activation of angiotensin converting enzyme (ACE)-2, nutrient/energy sensors sirtuin-1 and AMP-activated kinase, as well as impaired antioxidant defense mediated by nuclear factor erythroid 2-related factor-2 (Nrf2). Dietary fructose excess may also contribute to NAFLD and CKD. NAFLD affects renal injury through lipoprotein dysmetabolism and altered secretion of the hepatokines fibroblast growth factor-21, fetuin-A, insulin-like growth factor-1, and syndecan-1...
October 2015: Trends in Molecular Medicine
https://www.readbyqxmd.com/read/26069285/altered-gut-liver-axis-and-hepatic-adiponectin-expression-in-osas-novel-mediators-of-liver-injury-in-paediatric-non-alcoholic-fatty-liver
#13
Valerio Nobili, Anna Alisi, Renato Cutrera, Guido Carpino, Cristiano De Stefanis, Valentina D'Oria, Rita De Vito, Salvatore Cucchiara, Eugenio Gaudio, Giovanni Musso
BACKGROUND: Mechanism(s) connecting obstructive sleep apnoea syndrome (OSAS) to liver injury in paediatric non-alcoholic fatty liver disease (NAFLD) are unknown. We hypothesised alterations in gut-liver axis and in the pool and phenotype of hepatic progenitor cells (HPCs) may be involved in OSAS-associated liver injury in NAFLD. METHODS: Eighty biopsy-proven NAFLD children (age, mean±SD, 11.4±2.0 years, 56% males, body mass index z-score 1.95±0.57) underwent a clinical-biochemical assessment, with measurement of insulin sensitivity, plasma cytokines, lipopolysaccharide (LPS), an intestinal permeability test and a standard polysomnography...
August 2015: Thorax
https://www.readbyqxmd.com/read/25873773/osas-related-inflammatory-mechanisms-of-liver-injury-in-nonalcoholic-fatty-liver-disease
#14
REVIEW
Elena Paschetta, Paola Belci, Anna Alisi, Daniela Liccardo, Renato Cutrera, Giovanni Musso, Valerio Nobili
Obstructive sleep apnoea syndrome (OSAS) is a common sleep disorder, affecting over 4% of the general population, and is associated with metabolic syndrome and cardiovascular disease, independent of obesity and traditional risk factors. OSAS has been recently connected to nonalcoholic fatty liver disease (NAFLD), the most common chronic liver disease in the world, which can be found in 30% of the general adult population. Several studies suggest that the chronic intermittent hypoxia (CIH) of OSAS patients may per se trigger liver injury, inflammation, and fibrogenesis, promoting NAFLD development and the progression from steatosis to steatohepatitis, cirrhosis, and hepatocellular carcinoma...
2015: Mediators of Inflammation
https://www.readbyqxmd.com/read/25753820/obeticholic-acid-and-resveratrol-in-nonalcoholic-fatty-liver-disease-all-that-is-gold-does-not-glitter-not-all-those-who-wander-are-lost
#15
Giovanni Musso
No abstract text is available yet for this article.
June 2015: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://www.readbyqxmd.com/read/25646328/isoleucine-to-methionine-substitution-at-residue-148-variant-of-pnpla3-gene-and-metabolic-outcomes-in-gestational-diabetes
#16
RANDOMIZED CONTROLLED TRIAL
Simona Bo, Roberto Gambino, Guido Menato, Stefania Canil, Valentina Ponzo, Silvia Pinach, Marilena Durazzo, Ezio Ghigo, Maurizio Cassader, Giovanni Musso
BACKGROUND: A single nucleotide polymorphism (SNP) of the patatin-like phospholipase-3 (PNPLA3)/adiponutrin gene (rs738409 C>G) is strongly associated with nonalcoholic fatty liver disease; to our knowledge, no data are available on the impact of this PNPLA3 SNP on liver and metabolic outcomes during pregnancy in patients with gestational diabetes (GD). OBJECTIVE: We evaluated the impact of the PNPLA3 rs738409 SNP on liver enzymes, metabolic indexes, and maternal and neonatal outcomes in 200 GD patients enrolled in a lifestyle intervention...
February 2015: American Journal of Clinical Nutrition
https://www.readbyqxmd.com/read/25250617/consuming-more-of-daily-caloric-intake-at-dinner-predisposes-to-obesity-a-6-year-population-based-prospective-cohort-study
#17
Simona Bo, Giovanni Musso, Guglielmo Beccuti, Maurizio Fadda, Debora Fedele, Roberto Gambino, Luigi Gentile, Marilena Durazzo, Ezio Ghigo, Maurizio Cassader
BACKGROUND/OBJECTIVES: It has been hypothesized that assuming most of the caloric intake later in the day leads to metabolic disadvantages, but few studies are available on this topic. Aim of our study was to prospectively examine whether eating more of the daily caloric intake at dinner leads to an increased risk of obesity, hyperglycemia, metabolic syndrome, and non-alcoholic fatty liver disease (NAFLD). SUBJECTS/METHODS: 1245 non-obese, non-diabetic middle-aged adults from a population-based cohort underwent a 3-day food record questionnaire at enrollment...
2014: PloS One
https://www.readbyqxmd.com/read/25050550/association-of-non-alcoholic-fatty-liver-disease-with-chronic-kidney-disease-a-systematic-review-and-meta-analysis
#18
REVIEW
Giovanni Musso, Roberto Gambino, James H Tabibian, Mattias Ekstedt, Stergios Kechagias, Masahide Hamaguchi, Rolf Hultcrantz, Hannes Hagström, Seung Kew Yoon, Phunchai Charatcharoenwitthaya, Jacob George, Francisco Barrera, Svanhildur Hafliðadóttir, Einar Stefan Björnsson, Matthew J Armstrong, Laurence J Hopkins, Xin Gao, Sven Francque, An Verrijken, Yusuf Yilmaz, Keith D Lindor, Michael Charlton, Robin Haring, Markus M Lerch, Rainer Rettig, Henry Völzke, Seungho Ryu, Guolin Li, Linda L Wong, Mariana Machado, Helena Cortez-Pinto, Kohichiroh Yasui, Maurizio Cassader
BACKGROUND: Chronic kidney disease (CKD) is a frequent, under-recognized condition and a risk factor for renal failure and cardiovascular disease. Increasing evidence connects non-alcoholic fatty liver disease (NAFLD) to CKD. We conducted a meta-analysis to determine whether the presence and severity of NAFLD are associated with the presence and severity of CKD. METHODS AND FINDINGS: English and non-English articles from international online databases from 1980 through January 31, 2014 were searched...
July 2014: PLoS Medicine
https://www.readbyqxmd.com/read/24695800/hospital-admissions-for-hypertensive-crisis-in-the-emergency-departments-a-large-multicenter-italian-study
#19
MULTICENTER STUDY
Giuliano Pinna, Claudio Pascale, Paolo Fornengo, Sebastiana Arras, Carmela Piras, Pietro Panzarasa, Gianpaolo Carmosino, Orietta Franza, Vincenzo Semeraro, Salvatore Lenti, Susanna Pietrelli, Sergio Panzone, Christian Bracco, Roberto Fiorini, Giovanni Rastelli, Daniela Bergandi, Bruno Zampaglione, Roberto Musso, Claudio Marengo, Giancarlo Santoro, Sergio Zamboni, Barbara Traversa, Maddalena Barattini, Graziella Bruno
Epidemiological data on the impact of hypertensive crises (emergencies and urgencies) on referral to the Emergency Departments (EDs) are lacking, in spite of the evidence that they may be life-threatening conditions. We performed a multicenter study to identify all patients aged 18 years and over who were admitted to 10 Italian EDs during 2009 for hypertensive crises (systolic blood pressure ≥220 mmHg and/or diastolic blood pressure ≥120 mmHg). We classified patients as affected by either hypertensive emergencies or hypertensive urgencies depending on the presence or the absence of progressive target organ damage, respectively...
2014: PloS One
https://www.readbyqxmd.com/read/24631738/incidence-and-outcome-of-invasive-fungal-diseases-after-allogeneic-stem-cell-transplantation-a-prospective-study-of-the-gruppo-italiano-trapianto-midollo-osseo-gitmo
#20
Corrado Girmenia, Anna Maria Raiola, Alfonso Piciocchi, Alessandra Algarotti, Marta Stanzani, Laura Cudillo, Clara Pecoraro, Stefano Guidi, Anna Paola Iori, Barbara Montante, Patrizia Chiusolo, Edoardo Lanino, Angelo Michele Carella, Elisa Zucchetti, Benedetto Bruno, Giuseppe Irrera, Francesca Patriarca, Donatella Baronciani, Maurizio Musso, Arcangelo Prete, Antonio Maria Risitano, Domenico Russo, Nicola Mordini, Domenico Pastore, Adriana Vacca, Francesco Onida, Sadia Falcioni, Giovanni Pisapia, Giuseppe Milone, Daniele Vallisa, Attilio Olivieri, Alessandro Bonini, Elio Castagnola, Simona Sica, Ignazio Majolino, Alberto Bosi, Alessandro Busca, William Arcese, Giuseppe Bandini, Andrea Bacigalupo, Alessandro Rambaldi, Anna Locasciulli
Epidemiologic investigation of invasive fungal diseases (IFDs) in allogeneic hematopoietic stem cell transplantation (allo-HSCT) may be useful to identify subpopulations who might benefit from targeted treatment strategies. The Gruppo Italiano Trapianto Midollo Osseo (GITMO) prospectively registered data on 1858 consecutive patients undergoing allo-HSCT between 2008 and 2010. Logistic regression analysis was performed to identify risk factors for proven/probable IFD (PP-IFD) during the early (days 0 to 40), late (days 41 to 100), and very late (days 101 to 365) phases after allo-HSCT and to evaluate the impact of PP-IFDs on 1-year overall survival...
June 2014: Biology of Blood and Marrow Transplantation
keyword
keyword
118574
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"